Department Of Pharmacy 2
51. Phytochemicals, Herbal Extracts, and Dietary Supplements for Metabolic Disease Management
52. Towards attaining universal health coverage in Kazakhstan: Challenges and important next steps
53. A comprehensive health effects assessment of the use of sanitizers and disinfectants during COVID-19 pandemic: a global survey
54. A comprehensive health effects assessment of the use of sanitizers and disinfectants during COVID-19 pandemic: a global survey
55. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
56. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
57. Biosynthesis of Secondary Metabolites Based on the Regulation of MicroRNAs
58. Lasia spinosa Chemical Composition and Therapeutic Potential: A Literature-Based Review
59. Natural Compounds or Their Derivatives against Breast Cancer: A Computational Study
60. Propolis: An update on its chemistry and pharmacological applications
61. The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021
62. The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021
63. The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021
64. Experimental and theoretical study of improved mesoporous titanium dioxide perovskite solar cell: The impact of modification with graphene oxide
65. Experimental and theoretical study of improved mesoporous titanium dioxide perovskite solar cell: The impact of modification with graphene oxide
66. Retraction notice to Experimental and theoretical study of improved mesoporous titanium dioxide perovskite solar cell: The impact of modification with graphene oxide(Heliyon, (2024), 10, 4, (e26633), (S2405844024026641), 10.1016/j.heliyon.2024.e26633)
67. Retraction notice to Experimental and theoretical study of improved mesoporous titanium dioxide perovskite solar cell: The impact of modification with graphene oxide(Heliyon, (2024), 10, 4, (e26633), (S2405844024026641), 10.1016/j.heliyon.2024.e26633)
68. Abnormal Porphyrin Metabolism in Autism Spectrum Disorder and Therapeutic Implications
69. An updated overview of anticancer effects of alternariol and its derivatives: underlying molecular mechanisms
70. Neuropharmacological Effects of Quercetin: A Literature-Based Review
71. Therapeutic strategies for rheumatic diseases and disorders: targeting redox imbalance and oxidative stress
72. Roles of Therapeutic Bioactive Compounds in Hepatocellular Carcinoma
73. A novel mouse wound model for scar tissue formation in abdominal muscle wall
74. Collagen-derived dipeptide Pro-Hyp administration accelerates muscle regenerative healing accompanied by less scarring after wounding on the abdominal wall in mice
75. Intracellular Survival of Biofilm-Forming MRSA OJ-1 by Escaping from the Lysosome and Autophagosome in J774A Cells Cultured in Overdosed Vancomycin
76. Intracellular Survival of Biofilm-Forming MRSA OJ-1 by Escaping from the Lysosome and Autophagosome in J774A Cells Cultured in Overdosed Vancomycin
77. Burden of chronic respiratory disease in Asia, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
78. Burden of chronic respiratory disease in Asia, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
79. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
80. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
81. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
82. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
83. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
84. Stimuli-responsive Hydrogels for Targeted Antibiotic Delivery in Bone Tissue Engineering
85. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
86. Development of composition and technology for obtaining antimicrobial composition based on mono- and sesquiterpenoids
87. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
88. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
89. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
90. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
91. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
92. The burden of cardiovascular events according to cardiovascular risk profile in adults from high-income, middle-income, and low-income countries (PURE): a cohort study
93. Wheat Straw Processing Effect Study on Their Enzymatic Hydrolysis by Trichoderma viride and Aspergillus аwamori Cultures
94. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
95. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
96. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
97. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
98. The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050
99. The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050
100. The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050
1 2 3 4